Showing 2011-2020 of 9943 results for "".
The Time is Now: Dermatology and Climate Change
https://practicaldermatology.com/topics/practice-management/the-time-is-now-dermatology-and-climate-change/19930/How are global warming and associated changes in weather affecting the presentation of skin diseases? And what opportunities do dermatologists have to help turn the tide of global warning? Misha Rosenbach, MD reviews the science and touches on opportunities for change.Conversations in Acne, Part 1
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-1/19867/As treatment options for acne expand, clinicians consider the potential to combine topical therapies or pair topicals with systemics, all while adhering to guidelines for care and prescribing antibiotics responsibly. In the first episode of this three-part series, host Neal Bhatia, MD speaks with HiCrisis Management: Office Operations, Part 2
https://practicaldermatology.com/topics/practice-management/crisis-management-office-operations-part-2/18182/Practice shut downs for COVID-19 will have long-term consequences for medical aesthetic practices. Deirdre Hooper, MD, Ashish Bhatia, MD, Kevin Pinski, MD, and Nancy Samolitis, MD share their predictions with host Neal Bhatia, MD.Anatomy Lesson: Targeting the Underlying Cause of Wrinkles with Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/anatomy-lesson-targeting-the-underlying-cause-of-wrinkles-with-injections/19778/Patients need to understand that addressing the underlying causes of wrinkles and folds such as changes in bony structures with injectables will provide a more natural result than simply chasing wrinkles and folds, says Jeanette M. Black, MD.Updates on AD Therapeutics
https://practicaldermatology.com/topics/atopic-dermatitis/updates-on-ad-therapeutics/19760/It's a "super-exciting" time in the world of atopic dermatitis because of a number of new developments happening very rapidly, shares Peter Lio, MD. Recent approvals and additional indications for treatments like dupilumab and crisaborole in pediatric populations have been welcome additions. And theInclusion is In
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/inclusion-is-in/19704/Until you know your biases, you can't address them, says Jeanine Downie, MD. Inspired by the Obagi Skinclusion inititiative, she addresses the problem of bias in aesthetic medicine.Get Real: People Matter
https://practicaldermatology.com/topics/practice-management/get-real-people-matter/19678/Successful and rewarding practice may have more to do with the people you work with than any other factor, says Eric Bernstein, MD. He recaps a session he participated in to prepare residents for practice.Check Mate: Ensuring Quality
https://practicaldermatology.com/topics/practice-management/check-mate-ensuring-quality/19677/To ensure consistency of care and that patients are properly prepped and cleared for treatment, Doris Day, MD has implemented checklists. She explains how the lists have improved staff management.Things You Must Do to Improve Your Dermatology Website
https://practicaldermatology.com/topics/practice-management/improvewebsite/19552/Your website acts as the digital face of your dermatology practice. While the nitty-gritty of the actual website may vary widely due to a host of factors, there are some basic essentials that no dermatology website can do without. In This Ekwa Marketing video, we discuss four such absolute essentialApproval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by heal